A prospective study of contraceptive use among African women in HIV-1 serodiscordant partnerships

Sexually Transmitted Diseases

Volumn 37, Issue 10, 2010, Pages 621-628

  Heffron, Renee ^a   Were, Edwin ^b   Celum, Connie ^a   Mugo, Nelly ^a,c   Ngure, Kenneth ^c   Kiarie, James ^a,c   Baeten, Jared M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b MOI UNIVERSITY   (Kenya)

^c KENYATTA NATIONAL HOSPITAL   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CHILD; CONDOM; CONTRACEPTION; CONTROLLED STUDY; DRUG USE; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HYSTERECTOMY; INTRAUTERINE CONTRACEPTIVE DEVICE; MAJOR CLINICAL STUDY; NEGRO; PROSPECTIVE STUDY; SOUTH AFRICA; UNSAFE SEX; UTERINE TUBE LIGATION;

ADOLESCENT; ADULT; AFRICA; AFRICA, EASTERN; AFRICA, SOUTHERN; CONDOMS; CONTRACEPTIVE AGENTS; FEMALE; HETEROSEXUALITY; HIV INFECTIONS; HIV SERONEGATIVITY; HIV-1; HUMANS; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SAFE SEX; SEXUAL PARTNERS;

EID: 77957255508     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e3181e1a162     Document Type: Article

References (20)

1. Sweat MD, O'Reilly KR, Schmid GP, et al. Cost-effectiveness of nevirapine to prevent mother-to-child HIV transmission in eight African countries. AIDS 2004; 18:1661-1671.
2. Wilcher R, Petruney T, Reynolds HW, et al. From effectiveness to impact: Contraception as an HIV prevention intervention. Sex Transm Infect 2008; 84(suppl 2):ii54 -ii60.
3. Reynolds HW, Janowitz B, Homan R, et al. The value of contraception to prevent perinatal HIV transmission. Sex Transm Dis 2006; 33:350-356.
4. Dunkle KL, Stephenson R, Karita E, et al. New heterosexually transmitted HIV infections in married or cohabiting couples in urban Zambia and Rwanda: An analysis of survey and clinical data. Lancet 2008; 371:2183-2191.
5. Laher F, Todd CS, Stibich MA, et al. A qualitative assessment of decisions affecting contraceptive utilization and fertility intentions among HIV-positive women in Soweto, South Africa. AIDS Behav 2009; 13(suppl 1):47-54.
6. Dyer S, Mokoena N, Maritz J, et al. Motives for parenthood among couples attending a level 3 infertility clinic in the public health sector in South Africa. Hum Reprod 2008; 23:352-357.
7. Lavreys L, Baeten JM, Martin HL Jr, et al. Hormonal contraception and risk of HIV-1 acquisition: Results of a 10-year prospective study. AIDS 2004; 18:695-697.
8. Morrison CS, Richardson BA, Mmiro F, et al. Hormonal contraception and the risk of HIV acquisition. Aids 2007; 21:85-95.
9. Cates W Jr, Steiner MJ. Dual protection against unintended pregnancy and sexually transmitted infections: What is the best contraceptive approach? Sex Transm Dis 2002; 29:168-174.
10. Lingappa JR, Kahle E, Mugo N, et al. Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: The partners study. PLoS One 2009; 4:e5272.
11. Celum C, Wald A, Lingappa JR, et al. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med 2010; 362:427-439.
12. Ngure K, Heffron R, Mugo N, et al. Successful increase in contraceptive uptake among Kenyan HIV-1-serodiscordant couples enrolled in an HIV-1 prevention trial. AIDS 2009; 23(suppl 1):S89-S95.
13. Stone KM, Reiff-Eldridge R, White AD, et al. Pregnancy outcomes following systemic prenatal acyclovir exposure: Conclusions from the international acyclovir pregnancy registry, 1984-1999. Birth Defects Res A Clin Mol Teratol 2004; 70:201-207.
14. UNICEF. The State of the World's Children 2009. New York, NY: United Nations Children's Fund (UNICEF), 2008.
15. Central Statistics Office (CSO), Ministry of Health (MOH), Tropical Diseases Research Centre (TDRC), University of Zambia, Macro International Inc. Zambia Demographic and Health Survey 2007. Calverton, MD: CSO, Macro International Inc, 2009.
16. Department of Health, Medical Research Council, OrcMacro. South Africa Demographic and Health Survey 2003. Pretoria, South Africa: Department of Health, 2007.
17. Uganda Bureau of Statistics, Macro International Inc. Uganda Demographic and Health Survey 2006. Calverton, MD: Uganda Bureau of Statistics, Macro International Inc, 2007.
18. Central Bureau of Statistics (CBS) [Kenya], Ministry of Health (MOH), ORC Macro. Kenya Demographic and Health Survey 2003. Calverton, MD: CBS, MOH, ORC Macro, 2004.
19. Martin HL Jr, Nyange PM, Richardson BA, et al. Hormonal contraception, sexually transmitted diseases, and risk of heterosexual transmission of human immunodeficiency virus type 1. J Infect Dis 1998; 178:1053-1059.
20. Bennett CL, Stinson TJ. Comparing cost-effectiveness analyses for the clinical oncology setting: The example of the Gynecologic Oncology Group 111 trial. Cancer Invest 2000; 18:261-268.